These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27693595)

  • 41. Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?
    Hoogendoorn M; Feenstra TL; Asukai Y; Briggs AH; Borg S; Dal Negro RW; Hansen RN; Jansson SA; Leidl R; Risebrough N; Samyshkin Y; Wacker ME; Rutten-van Mölken MPMH
    Value Health; 2016; 19(6):800-810. PubMed ID: 27712708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and molecular markers in COPD.
    Gonçalves I; Guimarães MJ; van Zeller M; Menezes F; Moita J; Simão P;
    Pulmonology; 2018; 24(4):250-259. PubMed ID: 29898875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
    Tufvesson E; Bjermer L; Ekberg M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biomarker discovery in asthma and COPD by proteomic approaches.
    Rossi R; De Palma A; Benazzi L; Riccio AM; Canonica GW; Mauri P
    Proteomics Clin Appl; 2014 Dec; 8(11-12):901-15. PubMed ID: 25186471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biomarkers for precision medicine in airways disease.
    Rooney C; Sethi T
    Ann N Y Acad Sci; 2015 Jun; 1346(1):18-32. PubMed ID: 26099690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic obstructive pulmonary disease: linking outcomes and pathobiology of disease modification.
    Rennard SI
    Proc Am Thorac Soc; 2006 May; 3(3):276-80. PubMed ID: 16636098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
    Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exacerbations of COPD.
    Pavord ID; Jones PW; Burgel PR; Rabe KF
    Int J Chron Obstruct Pulmon Dis; 2016; 11 Spec Iss(Spec Iss):21-30. PubMed ID: 26937187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microfibrillar-associated protein 4: a potential biomarker of chronic obstructive pulmonary disease.
    Johansson SL; Roberts NB; Schlosser A; Andersen CB; Carlsen J; Wulf-Johansson H; Sækmose SG; Titlestad IL; Tornoe I; Miller B; Tal-Singer R; Holmskov U; Vestbo J; Sorensen GL
    Respir Med; 2014 Sep; 108(9):1336-44. PubMed ID: 25022422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
    Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
    Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Moving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine--a critical view.
    Lopez-Campos JL; Bustamante V; Muñoz X; Barreiro E
    COPD; 2014 Sep; 11(5):591-602. PubMed ID: 24914771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulatory Forum Opinion Piece*: Veterinary Pathologists in Translational Pharmacology and Biomarker Integration in Drug Discovery and Development.
    Ramaiah SK; Walker DB
    Toxicol Pathol; 2016 Feb; 44(2):137-46. PubMed ID: 26839329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introduction to precision medicine in COPD.
    Leung JM; Obeidat M; Sadatsafavi M; Sin DD
    Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30679189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Practical management problems of stable chronic obstructive pulmonary disease in the elderly.
    Pistelli R; Ferrara L; Misuraca C; Bustacchini S
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S43-8. PubMed ID: 22209930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systems Medicine: from molecular features and models to the clinic in COPD.
    Gomez-Cabrero D; Menche J; Cano I; Abugessaisa I; Huertas-Migueláñez M; Tenyi A; Marin de Mas I; Kiani NA; Marabita F; Falciani F; Burrowes K; Maier D; Wagner P; Selivanov V; Cascante M; Roca J; Barabási AL; Tegnér J
    J Transl Med; 2014 Nov; 12 Suppl 2(Suppl 2):S4. PubMed ID: 25471042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel outcomes and end points: biomarkers in chronic obstructive pulmonary disease clinical trials.
    Woodruff PG
    Proc Am Thorac Soc; 2011 Aug; 8(4):350-5. PubMed ID: 21816991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.